berberine has been researched along with Blood Pressure, High in 12 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine, extracted from Coptis Root and Phellodendron Chinese, has been frequently used for the adjuvant treatment of type 2 diabetes mellitus, hyperlipidemia, and hypertension in China." | 8.91 | Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. ( Dong, F; Fan, J; Lan, J; Sun, G; Yan, Z; Zhao, Y; Zheng, W, 2015) |
| "Hypertension is the highest risk factor for disease globally." | 6.72 | Berberine for the treatment of hypertension: A systematic review. ( Atherton, I; Suadoni, MT, 2021) |
| "Berberine, extracted from Coptis Root and Phellodendron Chinese, has been frequently used for the adjuvant treatment of type 2 diabetes mellitus, hyperlipidemia, and hypertension in China." | 4.91 | Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. ( Dong, F; Fan, J; Lan, J; Sun, G; Yan, Z; Zhao, Y; Zheng, W, 2015) |
| "The current study investigated the mechanism underlying the therapeutic effects of berberine in the vasculature in hypertension." | 4.02 | Berberine ameliorates vascular dysfunction by a global modulation of lncRNA and mRNA expression profiles in hypertensive mouse aortae. ( Han, W; Li, L; Liu, L; Tan, N; Zhang, Y; Zong, Y, 2021) |
| "Berberine could delay the onset and attenuate the severity of hypertension, as well as ameliorate hypertension-induced renal damage in SHR rats." | 3.81 | Anti-hypertensive and renoprotective effects of berberine in spontaneously hypertensive rats. ( Guo, Z; Sun, H; Zhang, H; Zhang, Y, 2015) |
| "Berberine, as an alkaloid found in many Chinese herbs, improves vascular functions in patients with cardiovascular diseases." | 3.81 | Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice. ( Guo, T; Peng, QS; Wang, J; Wang, SX; Yue, SW, 2015) |
| "Hypertension is the highest risk factor for disease globally." | 2.72 | Berberine for the treatment of hypertension: A systematic review. ( Atherton, I; Suadoni, MT, 2021) |
| "Berberine has several preventive effects on cardiovascular diseases." | 1.46 | Berberine promotes ischemia-induced angiogenesis in mice heart via upregulation of microRNA-29b. ( Jian, X; Li, P; Ping, S; Wan, GR; Yin, YL; Yu, HY; Zhu, ML, 2017) |
| "Treated with berberine for 4 weeks, elevated blood pressure and heightened levels of urine protein, blood urea nitrogen and serum creatinine in model rats were depressed significantly (P < 0." | 1.37 | [Effects and mechanism of berberine on the hypertensive renal injury rats induced by enriched high fat-salt-fructose diet]. ( Cai, Y; Li, HB; Lv, JH; Qi, CL, 2011) |
| "Berberine is a natural isoquinoline alkaloid found in plants of the Ranunculaceae and Berberidaceae families." | 1.30 | The antihypertensive effect of the berberine derivative 6-protoberberine in spontaneously hypertensive rats. ( Chan, P; Chen, YJ; Cheng, JT; Hong, SH; Liu, JC; Tomlinson, B, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Suadoni, MT | 1 |
| Atherton, I | 1 |
| Tan, N | 1 |
| Zhang, Y | 3 |
| Li, L | 1 |
| Zong, Y | 1 |
| Han, W | 1 |
| Liu, L | 2 |
| Zhu, ML | 1 |
| Yin, YL | 1 |
| Ping, S | 1 |
| Yu, HY | 1 |
| Wan, GR | 1 |
| Jian, X | 1 |
| Li, P | 1 |
| Tian, H | 1 |
| Kang, YM | 1 |
| Gao, HL | 1 |
| Shi, XL | 1 |
| Fu, LY | 1 |
| Li, Y | 1 |
| Jia, XY | 1 |
| Liu, KL | 1 |
| Qi, J | 1 |
| Li, HB | 2 |
| Chen, YM | 1 |
| Chen, WS | 1 |
| Cui, W | 1 |
| Zhu, GQ | 1 |
| Yu, XJ | 1 |
| Lan, J | 1 |
| Zhao, Y | 1 |
| Dong, F | 1 |
| Yan, Z | 1 |
| Zheng, W | 1 |
| Fan, J | 1 |
| Sun, G | 1 |
| Liu, J | 1 |
| Huang, Z | 1 |
| Yu, X | 1 |
| Zhang, X | 1 |
| Dou, D | 1 |
| Huang, Y | 1 |
| Guo, Z | 1 |
| Sun, H | 1 |
| Zhang, H | 1 |
| Wang, J | 1 |
| Guo, T | 1 |
| Peng, QS | 1 |
| Yue, SW | 1 |
| Wang, SX | 1 |
| Mazza, A | 1 |
| Lenti, S | 1 |
| Schiavon, L | 1 |
| Zuin, M | 1 |
| D'Avino, M | 1 |
| Ramazzina, E | 1 |
| Casiglia, E | 1 |
| Cai, Y | 1 |
| Qi, CL | 1 |
| Lv, JH | 1 |
| FACQUET, J | 1 |
| Liu, JC | 1 |
| Chan, P | 1 |
| Chen, YJ | 1 |
| Tomlinson, B | 1 |
| Hong, SH | 1 |
| Cheng, JT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Berberine on Cardiovascular Disease Risk Factors: a Mechanistic Randomized Controlled Trial[NCT03770325] | Phase 2/Phase 3 | 84 participants (Actual) | Interventional | 2019-04-01 | Completed | ||
| A Single-center, Randomized, Open-label, Controlled, Dose-escalating, Parallel-group Study to Assess the Anti-platelet Effect of Berberine in Patients Receiving Aspirin and Clopidogrel After Percutaneous Coronary Intervention[NCT03378934] | Phase 4 | 64 participants (Anticipated) | Interventional | 2018-09-26 | Recruiting | ||
| A Double-blind, Randomized, Placebo-controlled Trial of Berberine as an Adjuvant to Treat Antipsychotic-induced Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders[NCT02983188] | Phase 2/Phase 3 | 113 participants (Actual) | Interventional | 2018-04-25 | Completed | ||
| The Effect of Berberine on the Secretion of Incretin in Normal Man[NCT05947370] | Early Phase 1 | 16 participants (Actual) | Interventional | 2022-10-12 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for berberine and Blood Pressure, High
| Article | Year |
|---|---|
Berberine for the treatment of hypertension: A systematic review.
Topics: Antihypertensive Agents; Berberine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Humans; H | 2021 |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Topics: Antihypertensive Agents; Berberine; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension | 2015 |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Topics: Antihypertensive Agents; Berberine; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension | 2015 |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Topics: Antihypertensive Agents; Berberine; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension | 2015 |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Topics: Antihypertensive Agents; Berberine; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension | 2015 |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Topics: Antihypertensive Agents; Berberine; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension | 2015 |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Topics: Antihypertensive Agents; Berberine; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension | 2015 |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Topics: Antihypertensive Agents; Berberine; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension | 2015 |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Topics: Antihypertensive Agents; Berberine; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension | 2015 |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Topics: Antihypertensive Agents; Berberine; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension | 2015 |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Topics: Antihypertensive Agents; Berberine; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension | 2015 |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Topics: Antihypertensive Agents; Berberine; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension | 2015 |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Topics: Antihypertensive Agents; Berberine; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension | 2015 |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Topics: Antihypertensive Agents; Berberine; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension | 2015 |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Topics: Antihypertensive Agents; Berberine; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension | 2015 |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Topics: Antihypertensive Agents; Berberine; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension | 2015 |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Topics: Antihypertensive Agents; Berberine; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension | 2015 |
1 trial available for berberine and Blood Pressure, High
| Article | Year |
|---|---|
Nutraceuticals for Serum Lipid and Blood Pressure Control in Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk.
Topics: Berberine; Biological Products; Blood Pressure; Cardiovascular Diseases; Diet; Dietary Supplements; | 2015 |
9 other studies available for berberine and Blood Pressure, High
| Article | Year |
|---|---|
Berberine ameliorates vascular dysfunction by a global modulation of lncRNA and mRNA expression profiles in hypertensive mouse aortae.
Topics: Angiotensin II; Animals; Aorta; Berberine; Blood Pressure; Gene Expression Profiling; Hypertension; | 2021 |
Berberine promotes ischemia-induced angiogenesis in mice heart via upregulation of microRNA-29b.
Topics: AMP-Activated Protein Kinases; Angiogenesis Inducing Agents; Animals; Berberine; Cell Proliferation; | 2017 |
Chronic infusion of berberine into the hypothalamic paraventricular nucleus attenuates hypertension and sympathoexcitation via the ROS/Erk1/2/iNOS pathway.
Topics: Animals; Arterial Pressure; Berberine; Hypertension; Male; MAP Kinase Signaling System; NADPH Oxidas | 2019 |
Berberine improves endothelial function by inhibiting endoplasmic reticulum stress in the carotid arteries of spontaneously hypertensive rats.
Topics: AMP-Activated Protein Kinases; Animals; Berberine; Carotid Arteries; Cyclooxygenase 2; Endoplasmic R | 2015 |
Anti-hypertensive and renoprotective effects of berberine in spontaneously hypertensive rats.
Topics: Animals; Berberine; Blood Pressure; Disease Models, Animal; Glomerular Filtration Rate; Hypertension | 2015 |
Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice.
Topics: Aging; Animals; Berberine; Blood Pressure; Cardiovascular Diseases; Hypertension; Mice; Organ Cultur | 2015 |
[Effects and mechanism of berberine on the hypertensive renal injury rats induced by enriched high fat-salt-fructose diet].
Topics: Animals; Berberine; Blood Pressure; Body Weight; Creatinine; Diet; Diet, High-Fat; Disease Models, A | 2011 |
[The action of tetrahydroberberine HC1 on arterial hypertension].
Topics: Alkaloids; Berberine; Hypertension | 1954 |
The antihypertensive effect of the berberine derivative 6-protoberberine in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Berberine; Blood Pressure; Cardiac Output; Central Nervous System; | 1999 |